Where can I find NAUT's financial statements?

Nautilus Biotechnolgy, Inc. (NAUT)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for NAUT?

Nautilus Biotechnolgy, Inc. (NAUT) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does NAUT update its statements?

Nautilus Biotechnolgy, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

NAUT

Nautilus Biotechnolgy, Inc.

NASDAQ·Biotechnology · Healthcare

$0.94$0.06+6.37%

After hours·$0.95+1.34%

Market cap$119.29M·Market closed·Aug 26 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of revenue	$2.84M+21.1%	—	$5.71M	$6.35M+11.4%	$6.47M+1.8%
Gross profit	−$2.84M−21.1%	$0.00+100.0%	−$5.71M	−$6.35M−11.4%	−$6.47M−1.8%
Research & development	$26.51M+162.8%	$37.67M+42.1%	$47.25M+25.4%	$50.48M+6.8%	$41.11M−18.6%
General & administrative	—	$25.95M	$28.90M+11.4%	$31.00M+7.3%	$25.73M−17.0%
SG&A (combined)	$21.15M+538.5%	$25.95M+22.7%	$28.90M+11.4%	$31.00M+7.3%	$25.73M−17.0%
Other operating expenses	—	—	−$5.71M	−$6.35M−11.4%	−$6.47M−1.8%
Total operating expenses	$47.66M+255.7%	$63.62M+33.5%	$70.45M+10.7%	$75.12M+6.6%	$60.37M−19.6%
Operating income	−$50.50M−220.7%	−$63.62M−26.0%	−$76.15M−19.7%	−$81.48M−7.0%	−$66.84M+18.0%
Interest income	$329.00K	$5.82M+1,667.8%	$12.55M+115.8%	$10.78M−14.1%	$7.87M−27.0%
Other income / (expense), net	$183.00K+46.4%	$5.69M+3,011.5%	$12.48M+119.1%	$10.70M−14.3%	$7.84M−26.7%
Income before tax	−$50.32M−222.1%	−$57.92M−15.1%	−$63.68M−9.9%	−$70.78M−11.2%	−$59.00M+16.6%
Net income	−$50.32M−222.1%	−$57.92M−15.1%	−$63.68M−9.9%	−$70.78M−11.2%	−$59.00M+16.6%

EPS (basic)	−$0.60−27.7%	−$0.46+23.3%	−$0.51−10.9%	−$0.56−9.8%	−$0.47+16.1%
EPS (diluted)	−$0.60−27.7%	−$0.46+23.3%	−$0.51−10.9%	−$0.56−9.8%	−$0.47+16.1%
Weighted avg shares (basic)	84,464,000	124,589,000	124,919,000	125,427,000	126,256,583
Weighted avg shares (diluted)	84,464,000	124,589,000	124,919,000	125,427,000	126,256,583

Depreciation & amortization	$2.84M+21.1%	$3.42M+20.2%	$1.85M−45.9%	$6.35M+243.6%	$6.47M+1.8%
EBITDA	−$47.47M−257.7%	−$60.08M−26.6%	−$61.83M−2.9%	−$64.43M−4.2%	−$52.54M+18.5%

Frequently Asked Questions About NAUT

Where can I find NAUT's financial statements?: Nautilus Biotechnolgy, Inc. (NAUT)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for NAUT?: Nautilus Biotechnolgy, Inc. (NAUT) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does NAUT update its statements?: Nautilus Biotechnolgy, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.